ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Biostock
|
60 |
14K |
5 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
14K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
Biostock
|
40 |
8.0K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
40
|
8.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
Biostock
|
74 |
16K |
0 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
16K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
Biostock
|
91 |
25K |
8 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
91
|
25K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Corporate Governance Statement
|
|
Biostock
|
4 |
1.4K |
0 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
4
|
1.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP HER2-radiodiagnostic shows imaging benefits
|
|
Biostock
|
23 |
8.0K |
1 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
23
|
8.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma CEO to retire in 2024
|
|
Biostock
|
69 |
27K |
2 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
69
|
27K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma CEO to retire in 2024
|
|
Biostock
|
69 |
27K |
4 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
69
|
27K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma CEO to retire in 2024
|
|
Biostock
|
69 |
27K |
2 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
69
|
27K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma CEO to retire in 2024
|
|
Biostock
|
69 |
27K |
11 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
69
|
27K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Interim Report and Half-Year Financial Results
|
|
Biostock
|
47 |
12K |
4 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
47
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Resignation of CFO / Company Secretary
|
|
Biostock
|
20 |
8.8K |
4 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
20
|
8.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Resignation of CFO / Company Secretary
|
|
Biostock
|
20 |
8.8K |
7 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
20
|
8.8K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Vitally important AGM tactics
|
|
Biostock
|
23 |
7.3K |
1 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
23
|
7.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
AstraZeneca and AZD0466
|
|
Biostock
|
6 |
2.0K |
4 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
6
|
2.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Tsunami of announcements pending?
|
|
Biostock
|
4 |
1.2K |
4 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
4
|
1.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Is this the week?
|
|
Biostock
|
5 |
1.2K |
1 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
5
|
1.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
CEO Fairley’s list of failures
|
|
Biostock
|
4 |
2.7K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
4
|
2.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
DEP-Gemcitabine
|
|
Biostock
|
28 |
6.7K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
28
|
6.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Share price disconnect and scaremongering
|
|
Biostock
|
19 |
4.6K |
4 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
19
|
4.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
DEP-Cabazitaxel
|
|
Biostock
|
15 |
3.6K |
1 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Latest quarterly update on AZD0466 today
|
|
Biostock
|
15 |
3.1K |
3 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
15
|
3.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
CEO Fairley’s list of failures
|
|
Biostock
|
4 |
2.7K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
4
|
2.7K
|
1
|
|
ASX - By Stock
|
SPL |
Radiotherapy
|
|
Biostock
|
0 |
266 |
3 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
0
|
266
|
3
|
|
ASX - By Stock
|
SPL |
Re:
DEP Licencing timing
|
|
Biostock
|
3 |
821 |
4 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
3
|
821
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Status quo to win out?
|
|
Biostock
|
17 |
3.6K |
3 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
17
|
3.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Vitally important AGM tactics
|
|
Biostock
|
23 |
7.3K |
2 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
23
|
7.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Why isn't Starpharma marketing in USA
|
|
Biostock
|
2 |
648 |
1 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
2
|
648
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Vote NO to resolution 3
|
|
Biostock
|
4 |
1.1K |
1 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
SPL |
Viraleze and BTB grant
|
|
Biostock
|
0 |
218 |
2 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
0
|
218
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notification regarding unquoted securities - SPL
|
|
Biostock
|
10 |
2.7K |
3 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
10
|
2.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notification regarding unquoted securities - SPL
|
|
Biostock
|
10 |
2.7K |
7 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
10
|
2.7K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
Biostock
|
33 |
8.9K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
33
|
8.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
Biostock
|
33 |
8.9K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
33
|
8.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Are you Ready???
|
|
Biostock
|
4 |
1.2K |
5 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
4
|
1.2K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution agreement for Hong Kong and Macau
|
|
Biostock
|
40 |
10K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
40
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Time for action!
|
|
Biostock
|
73 |
21K |
3 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
73
|
21K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
The Viraleze India betrayal
|
|
Biostock
|
7 |
2.2K |
4 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
7
|
2.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ministerial Complaint and Freedom of Information
|
|
Biostock
|
12 |
4.7K |
2 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
12
|
4.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
The never ending jab
|
|
Biostock
|
7 |
2.3K |
2 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
7
|
2.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Has TGA approved VIRALEZE™ in Australia?
|
|
Biostock
|
35 |
11K |
2 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Time for action!
|
|
Biostock
|
73 |
21K |
3 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
73
|
21K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
68K |
0 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
253
|
68K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Time for action!
|
|
Biostock
|
73 |
21K |
3 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
73
|
21K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Is this legal ASIC
|
|
Biostock
|
12 |
3.4K |
3 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
12
|
3.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Unless there will be some rabbits pulled out of hat.
|
|
Biostock
|
3 |
1.1K |
5 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
3
|
1.1K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
For the newbies - worth reading - Dendrimers coming of Age
|
|
Biostock
|
20 |
5.6K |
0 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
20
|
5.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform
|
|
Biostock
|
16 |
6.1K |
1 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
For the newbies - worth reading - Dendrimers coming of Age
|
|
Biostock
|
20 |
5.6K |
3 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
20
|
5.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform
|
|
Biostock
|
16 |
6.1K |
1 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|